Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Yandex began testing unmanned cars without a driver in the cabin

10/25/23 YNDX

X5 Retail Group reported for 9 months of 2023

10/25/23 FIVE

Unipro increased electricity generation by 4.1%

10/25/23 UPRO

Teladoc Health reported for 9 months of 2023

10/25/23 TDOC

Henderson begins accepting IPO filings

10/25/23 HNFG

Visa announced a quarterly dividend

10/25/23 V

Visa reported for fiscal year 2023

10/25/23 V

Microsoft reported for 3 months of fiscal year 2024

10/25/23 MSFT

Alphabet reported for 9 months of 2023

10/25/23 GOOG

The Wells Fargo & Co announced a quarterly dividend

10/25/23 WFC